BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Duan F, Bai YH, Cui L, Li XH, Yan JY, Wang MQ. Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(1): 92-100 [PMID: 31966917 DOI: 10.4251/wjgo.v12.i1.92]
URL: https://www.wjgnet.com/1948-5182/full/v12/i1/92.htm
Number Citing Articles
1
Ronald S. Arellano. What’s New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 UpdateCurrent Oncology Reports 2020; 22(10) doi: 10.1007/s11912-020-00967-y
2
Liang Zhang, Kuishuai Xu, Xuehui Zhang, Linqian Li, Jing Chong, Ning Yu. A meta-analysis and trial sequential analysis of high intensity focused ultrasound ablation combined with transhepatic arterial chemotherapy and embolization for hepatomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1025177
3
Yun-Long Qin, Shuai Wang, Fei Chen, Hong-Xiu Liu, Kui-Tao Yue, Xi-Zhen Wang, Hou-Fa Ning, Peng Dong, Xiang-Rong Yu, Guang-Zhi Wang. Prediction of outcomes by diffusion kurtosis imaging in patients with large (≥5 cm) hepatocellular carcinoma after liver resection: A retrospective studyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.939358
4
Chao An, Yan Fu, Wang Li, Mengxuan Zuo, Peihong Wu. Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapyCancer 2023; 129(14): 2235 doi: 10.1002/cncr.34764
5
Chao An, Wang Yao, Mengxuan Zuo, Wang Li, Qifeng Chen, Peihong Wu. Pseudo-capsulated Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial ChemoembolizationAcademic Radiology 2024; 31(3): 833 doi: 10.1016/j.acra.2023.06.021
6
Shen Zhang, Bin-Yan Zhong, Lei Zhang, Wan-Sheng Wang, Cai-Fang Ni. Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-propositionWorld Journal of Gastrointestinal Surgery 2022; 14(6): 528-537 doi: 10.4240/wjgs.v14.i6.528
7
Zeno Sparchez, Pompilia Radu, Adrian Bartos, Iuliana Nenu, Rares Craciun, Tudor Mocan, Adelina Horhat, Mihaela Spârchez, Jean-François Dufour. Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?World Journal of Gastrointestinal Oncology 2021; 13(12): 1896-1918 doi: 10.4251/wjgo.v13.i12.1896
8
Lin Zhou, Jing Wang, Shao-cheng Lyu, Li-chao Pan, Xian-jie Shi, Guo-sheng Du, Qiang He. PD-L1+NEUT, Foxp3+Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2021; 20: 153303382110458 doi: 10.1177/15330338211045820
9
Chunhui Zhou, Changli Peng, Fei Liu, Juxiong Xiao, Gang Li, Changyong Chen, Liangrong Shi, Haiping Li. Evaluation of the efficacy and safety of CalliSpheres® microsphere-transarterial chemoembolization in large hepatocellular carcinomaJournal of Cancer Research and Therapeutics 2023; 19(6): 1575 doi: 10.4103/jcrt.jcrt_218_23